Table 3 Univariate analysis of 30 days mortality, complications and 1 year mortality.
From: Predictors of long time survival after lung cancer surgery: A retrospective cohort study
n | 30 days mortality | p | Complications* | p | 1 year mortality | p | |
|---|---|---|---|---|---|---|---|
Sex | 0.16 | 0.37 | 0.07 | ||||
Female | 48 | 0% | 31.3% | 10.4% | |||
Male | 100 | 4% | 38.8% | 23.0% | |||
Age | 0.02 | 0.002 | <0.001 | ||||
< 70 years | 86 | 0% | 25.9% | 9.3% | |||
≥ 70 years | 62 | 6.5% | 50.8% | 32.3% | |||
Preoperative stage | 0.09 | 0.18 | 0.04 | ||||
IA (T1 N0 M0) | 64 | 0% | 31.3% | 10.9% | |||
IB (T2 N0 M0) | 68 | 5.9% | 36.4% | 22.1% | |||
II-IV | 16 | 0% | 56.3% | 37.5% | |||
Operation type | 0.001 | 0.29 | 0.11 | ||||
Lobectomy | 97 | 0% | 31.3% | 15.5% | |||
Pneumonectomy | 30 | 13.3% | 46.7% | 33.3% | |||
Bilobectomy | 16 | 0% | 40% | 18.8% | |||
Wedge | 5 | 0% | 60% | 0% | |||
Histology | 0.57 | 0.35 | 0.21 | ||||
Adenocarcinoma | 73 | 1.4% | 33.3% | 13.7% | |||
Squamous cell carcinoma | 53 | 3.8% | 42.3% | 22.6% | |||
Large cell carcinoma | 14 | 7.1% | 42.9% | 35.7% | |||
Other non-small cell carcinoma | 8 | 0% | 12.5% | 12.5% | |||
Coronary heart disease | 0.03 | 0.84 | 0.91 | ||||
No previous coronary disease | 107 | 0.9% | 36.8% | 18.7% | |||
Previous coronary disease | 41 | 7.3% | 35.0% | 19.5% | |||
Pulmonary function | 0.22 | 0.40 | 0.86 | ||||
FEV1 ≥ 80% | 62 | 4.8% | 33.9% | 19.4% | |||
FEV1<80% | 77 | 1.3% | 40.8% | 18.2% |